Shankar Siva provides an overview of the RAPPORT study of pembrolizumab plus stereotactic ablative body radiotherapy for the treatment of renal cell carcinoma with oligometastases (3:07).
14-02-2021 | ASCO GU 2021 | Conference coverage | Video
14-02-2021 | ASCO GU 2021 | Conference coverage | Video
Shankar Siva provides an overview of the RAPPORT study of pembrolizumab plus stereotactic ablative body radiotherapy for the treatment of renal cell carcinoma with oligometastases (3:07).